Insider: Flanagan W. Michael Chief Scientific Officer - Avidity Biosciences, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 85,093 | 0 | 85,093 |
| Value | $1,143,649.92 | $0.00 | $1,143,649.92 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/21/2026 | DDS | 2,558 | Direct | COM | $72.45 | $185,327.10 | 85,093 |
| 01/21/2026 | DDS | 3,976 | Direct | COM | $72.45 | $288,061.20 | 87,651 |
| 01/07/2026 | DDS | 2,373 | Direct | COM | $72.23 | $171,401.79 | 91,627 |
| 09/11/2025 | DDS | 20,000 | Direct | COM | $38.94 | $778,702.00 | 80,195 |
| 06/11/2025 | DDS | 20,000 | Direct | COM | $32.88 | $657,694.00 | 80,195 |
| 03/20/2025 | DDS | 11,780 | Direct | COM | $31.06 | $365,867.95 | 80,195 |
| 03/11/2025 | DDS | 20,000 | Direct | COM | $30.13 | $602,614.00 | 91,975 |
| 01/21/2025 | DDS | 3,860 | Direct | COM | $28.60 | $110,383.26 | 93,787 |
| 01/21/2025 | DDS | 1,812 | Direct | COM | $28.59 | $51,808.70 | 91,975 |
| 12/18/2024 | DDS | 12,742 | Direct | COM | $32.66 | $416,153.72 | 72,647 |
| 12/11/2024 | DDS | 24,000 | Direct | COM | $35.77 | $858,400.80 | 85,389 |
| 10/01/2024 | DDS | 62,500 | Direct | COM | $47.62 | $2,976,112.50 | 85,389 |
| 09/23/2024 | DDS | 13,153 | Direct | COM | $44.00 | $578,737.26 | 72,718 |
| 09/23/2024 | DDS | 11,847 | Direct | COM | $43.89 | $519,995.63 | 85,389 |
| 09/11/2024 | DDS | 62,500 | Direct | COM | $40.40 | $2,525,012.50 | 75,765 |
| 09/11/2024 | DDS | 14,894 | Direct | COM | $40.40 | $601,675.90 | 60,871 |
| 09/11/2024 | DDS | 34,000 | Direct | COM | $40.40 | $1,373,555.80 | 75,765 |
| 06/18/2024 | DDS | 10,106 | Direct | COM | $39.13 | $395,444.75 | 50,765 |
| 01/22/2024 | DDS | 4,129 | Direct | COM | $10.13 | $41,826.77 | 35,871 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research